Diaceutics (DXRX) Stock Chart & Stock Price History GBX 120.50 -3.50 (-2.82%) (As of 11:06 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades Diaceutics Stock Price Performance 5 Day Performance-0.41%1 Month Performance+2.12%3 Month Performance-10.07%6 Month Performance-1.71%Year-To-Date Performance+38.51%1 Year Performance+30.98% Receive DXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Musk threatens Liberal’s fake “energy crisis” (Ad)Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now DXRX Stock Chart for Wednesday, December, 18, 2024 DXRX Chart by TradingView Diaceutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/18/2024GBX 122GBX 120.50-1.23%GBX 128GBX 120.5035,123 shs£101.79 million12/17/2024GBX 119.50GBX 122+2.09%GBX 125.40GBX 12032,192 shs£103.05 million12/16/2024GBX 121GBX 119.50-1.24%GBX 119.50GBX 119262,877 shs£100.94 million12/13/2024GBX 122GBX 121-0.82%GBX 121GBX 12030,495 shs£102.21 million12/12/2024GBX 119.60GBX 122+2.01%GBX 122GBX 1181.02 million shs£103.05 million12/11/2024GBX 116.50GBX 119.60+2.66%GBX 122GBX 116.202.47 million shs£101.03 million Get the Latest News and Ratings for DXRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. 12/10/2024GBX 116.50GBX 116.50GBX 116.50GBX 115.2535,247 shs£98.41 million12/09/2024GBX 116.32GBX 116.50+0.15%GBX 118GBX 11697,130 shs£98.41 million12/06/2024GBX 116.47GBX 116.32-0.13%GBX 116.90GBX 115201,594 shs£98.26 million12/05/2024GBX 116.40GBX 116.47+0.06%GBX 117.75GBX 115200,351 shs£98.39 million12/04/2024GBX 116.50GBX 116.40-0.09%GBX 117GBX 115163,065 shs£98.32 million12/03/2024GBX 116GBX 116.50+0.43%GBX 116.50GBX 11535,000 shs£98.41 million12/02/2024GBX 118.50GBX 116-2.11%GBX 119GBX 116106,396 shs£97.99 million11/29/2024GBX 118.50GBX 117.32-0.99%GBX 118.50GBX 117.1050,603 shs£99.10 million11/28/2024GBX 115.50GBX 118.50+2.60%GBX 122GBX 11757,086 shs£100.10 million11/27/2024GBX 115GBX 115.50+0.43%GBX 116.99GBX 115.5043,308 shs£97.56 million11/26/2024GBX 116GBX 115-0.86%GBX 116GBX 11542,558 shs£97.14 million11/25/2024GBX 117.50GBX 116-1.28%GBX 117GBX 1155,489 shs£97.99 million11/22/2024GBX 117.10GBX 117.63+0.45%GBX 117.63GBX 11515,095 shs£99.36 million11/21/2024GBX 118GBX 117.10-0.76%GBX 120GBX 1175,293 shs£98.91 million11/20/2024N/AGBX 118GBX 119GBX 11866,324 shs£99.68 million11/18/2024GBX 119GBX 118-0.84%GBX 119.40GBX 11724,492 shs£99.68 million Related Companies ANGLE Stock Chart Abingdon Health Stock Chart genedrive Stock Chart Proteome Sciences Stock Chart GENinCode Stock Chart Verici Dx Stock Chart LungLife AI Stock Chart Integrated Diagnostics Stock Chart LLA.L,0P0001T9GN,0 Stock Chart MaxCyte Stock Chart Receive DXRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Diaceutics and its competitors with MarketBeat's FREE daily newsletter. This page (LON:DXRX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Diaceutics PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Diaceutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DXRX Stock Alerts